ABVC BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABVC BioPharma and other ETFs, options, and stocks.About ABVC
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002.
CEOUttam Yashwant Patil
CEOUttam Yashwant Patil
Employees19
Employees19
HeadquartersFremont, California
HeadquartersFremont, California
Founded1990
Founded1990
Employees19
Employees19
ABVC Key Statistics
Market cap50.05M
Market cap50.05M
Price-Earnings ratio-9.10
Price-Earnings ratio-9.10
Dividend yield—
Dividend yield—
Average volume88.56K
Average volume88.56K
High today—
High today—
Low today—
Low today—
Open price$2.06
Open price$2.06
Volume0.00
Volume0.00
52 Week high$5.48
52 Week high$5.48
52 Week low$0.40
52 Week low$0.40
Stock Snapshot
With a market cap of 50.05M, ABVC BioPharma(ABVC) trades at $1.79. The stock has a price-to-earnings ratio of -9.10.
ABVC BioPharma(ABVC) stock opened on 2025-12-18 at $2.06. The price climbed to — and dipped to —.
ABVC BioPharma(ABVC) shares are trading with a volume of 0, against a daily average of 88.56K.
During the past year, ABVC BioPharma(ABVC) stock moved between $0.40 at its lowest and $5.48 at its peak.
During the past year, ABVC BioPharma(ABVC) stock moved between $0.40 at its lowest and $5.48 at its peak.
People also own
Based on the portfolios of people who own ABVC. This list is generated using Robinhood data, and it’s not a recommendation.